Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001543174-25-000002
Filing Date
2025-05-27
Accepted
2025-05-27 18:17:20
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748384233.html 4  
1 FORM 4 wk-form4_1748384233.xml 4 3265
  Complete submission text file 0001543174-25-000002.txt   4876
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9220 KIRBY DRIVE SUITE 500 HOUSTON TX 77054
Business Address
TANNENBAUM RENEE P (Reporting) CIK: 0001543174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 25990280